# Ramesh K. Ramanathan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ramesh-k-ramanathan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,500 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 72 |
| i10-index | 203 |
| Last Known Institution | Ironwood Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5113733729 |
| Works | 467 |

## Researcher papers

- [First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas](https://scholariq.org/papers/first-in-human-phase-i-study-of-copanlisib-bay-80-6946-an-intravenous-pan-class/)
- [Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>](https://scholariq.org/papers/herceptin-and-gemcitabine-for-metastatic-pancreatic-cancers-that-overexpress-her/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

## Researcher university

- [Ironwood Pharmaceuticals (United States)](https://scholariq.org/institutions/ironwood-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.